Login to Your Account

Pharma: Other News To Note

Monday, August 13, 2012

• Mylan Inc. said its subsidiary Mylan Pharmaceuticals, of Pittsburgh, received FDA approval of its abbreviated new drug application (ANDA) for lithium carbonate extended-release tablets USP, 450 mg, to treat manic episodes of manic depressive illness. The FDA also approved Mylan's ANDA for a generic version of Provigil (modafinil, Cephalon Inc.).

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription